国药一致：上半年归母净利润6.66亿元，同比下降10.43%

Core Viewpoint - The company reported a decline in both revenue and net profit for the first half of the year, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 36.797 billion yuan, a year-on-year decrease of 2.62% [1] - The net profit attributable to shareholders was 666 million yuan, reflecting a year-on-year decline of 10.43% [1] - The basic earnings per share were reported at 1.2 yuan [1]